185 related articles for article (PubMed ID: 8065846)
21. Executive functioning in children and adolescents with phenylketonuria.
VanZutphen K; Packman W; Sporri L; Needham M; Morgan C; Weisiger K; Packman S
Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394
[TBL] [Abstract][Full Text] [Related]
22. Outcome of early detected and early treated phenylketonuria patients.
Rylance G
Postgrad Med J; 1989; 65 Suppl 2():S7-9. PubMed ID: 2622815
[TBL] [Abstract][Full Text] [Related]
23. [Effect of dietary non-compliance on development in phenylketonuria--studies of 14-year-old patients].
Theile H; Graustein I; Wässer S; Bührdel P
Padiatr Padol; 1990; 25(1):19-23. PubMed ID: 2326088
[TBL] [Abstract][Full Text] [Related]
24. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
Weigel C; Kiener C; Meier N; Schmid P; Rauh M; Rascher W; Knerr I
Ann Nutr Metab; 2008; 53(2):91-5. PubMed ID: 18946205
[TBL] [Abstract][Full Text] [Related]
25. Phenylalanine control and family functioning in early-treated phenylketonuria.
Reber M; Kazak AE; Himmelberg P
J Dev Behav Pediatr; 1987 Dec; 8(6):311-7. PubMed ID: 3429669
[TBL] [Abstract][Full Text] [Related]
26. Neuropsychological deficits in early treated phenylketonuric children.
Pennington BF; van Doorninck WJ; McCabe LL; McCabe ER
Am J Ment Defic; 1985 Mar; 89(5):467-74. PubMed ID: 3993693
[TBL] [Abstract][Full Text] [Related]
27. Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria.
Sharman R; Sullivan K; Young R; McGill J
Clin Genet; 2009 Feb; 75(2):169-74. PubMed ID: 19215250
[TBL] [Abstract][Full Text] [Related]
28. Neuropsychological function in mild hyperphenylalaninemia.
Smith ML; Saltzman J; Klim P; Hanley WB; Feigenbaum A; Clarke JT
Am J Ment Retard; 2000 Mar; 105(2):69-80. PubMed ID: 10755172
[TBL] [Abstract][Full Text] [Related]
29. Outcome of treatment in young adults with phenylketonuria detected by routine neonatal screening between 1964 and 1971.
Beasley MG; Costello PM; Smith I
Q J Med; 1994 Mar; 87(3):155-60. PubMed ID: 8208903
[TBL] [Abstract][Full Text] [Related]
30. The Adolescent Adjustment Profile (AAP) in comparisons of patients with obesity, phenylketonuria or neurobehavioural disorders.
Olsson GM; Mårild S; Alm J; Brodin U; Rydelius PA; Marcus C
Nord J Psychiatry; 2008; 62(1):66-76. PubMed ID: 18389428
[TBL] [Abstract][Full Text] [Related]
31. Social quotients of children with phenylketonuria before and after discontinuation of dietary therapy.
Matthews WS; Barabas G; Cusack E; Ferrari M
Am J Ment Defic; 1986 Jul; 91(1):92-4. PubMed ID: 3740120
[TBL] [Abstract][Full Text] [Related]
32. Cognitive profile and mental health in adult phenylketonuria: A PKU-COBESO study.
Jahja R; Huijbregts SCJ; de Sonneville LMJ; van der Meere JJ; Legemaat AM; Bosch AM; Hollak CEM; Rubio-Gozalbo ME; Brouwers MCGJ; Hofstede FC; de Vries MC; Janssen MCH; van der Ploeg AT; Langendonk JG; van Spronsen FJ
Neuropsychology; 2017 May; 31(4):437-447. PubMed ID: 28318283
[TBL] [Abstract][Full Text] [Related]
33. Intellectual development of the patients of the German Collaborative Study of children treated for phenylketonuria.
Burgard P; Schmidt E; Rupp A; Schneider W; Bremer HJ
Eur J Pediatr; 1996 Jul; 155 Suppl 1():S33-8. PubMed ID: 8828606
[TBL] [Abstract][Full Text] [Related]
34. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
Diamond A; Prevor MB; Callender G; Druin DP
Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
[TBL] [Abstract][Full Text] [Related]
35. [An adult patient with phenylketonuria before and one year after reinstitution of diet therapy].
Tiefenthaler M; Seidl R; Scheibenreiter S; Wandl-Vergesslich K; Stöckler-Ipsiroglu S
Wien Klin Wochenschr; 1999 Jan; 111(1):33-6. PubMed ID: 10067268
[TBL] [Abstract][Full Text] [Related]
36. Management of phenylketonuria: South Australian experience of 13 cases.
Robertson EF; Hill GN; Cashel K; Rooney J; Brummitt R; Pollard AC
Med J Aust; 1976 May; 1(18):647-50. PubMed ID: 950936
[TBL] [Abstract][Full Text] [Related]
37. [Correlation between biochemical-biological parameters and intellectual development in treated phenylketonuria children].
Cobet G; Witkowski R
Samml Zwangl Abh Geb Psychiatr Neurol; 1982; 50():269-75. PubMed ID: 7157122
[No Abstract] [Full Text] [Related]
38. Do adult patients with phenylketonuria improve their quality of life after introduction/resumption of a phenylalanine-restricted diet?
Gassió R; Campistol J; Vilaseca MA; Lambruschini N; Cambra FJ; Fusté E
Acta Paediatr; 2003 Dec; 92(12):1474-8. PubMed ID: 14971801
[TBL] [Abstract][Full Text] [Related]
39. Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria.
Schulpis KH; Tsakiris S; Traeger-Synodinos J; Papassotiriou I
Clin Biochem; 2005 Mar; 38(3):239-42. PubMed ID: 15708545
[TBL] [Abstract][Full Text] [Related]
40. [Brain white matter lesions of children with phenylketonuria before and after treatment].
Wang ZX; Zhou ZS; Yu WM
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):13-6. PubMed ID: 16522231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
